Development of cerebral microbleeds and its impact on cognitive function in adult patients receiving medical management alone for ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Masahiro YabukiYoshitaka KuboKei KitakamiDaisuke OomoriShunrou FujiwaraKenji YoshidaMasakazu KobayashiKuniaki OgasawaraPublished in: Neurological research (2022)
The incidence of an interval increase in CMBs was 15% per 5 years in adult patients receiving medical management alone for ischemic MMD, and this increase was associated with a decline in cognitive decline.